5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
Clinical trial NCT02435654 · COMPLETED
Trial details
- NCT number
- NCT02435654
- Sponsor
- Kunming Medical University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-12-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.